Gair Ford, PhDRegulatory CMC Director at Astrazeneca
Gair Ford PhD has over 20 years’ experience in the pharmaceutical industry as process development chemist and is currently a regulatory CMC director. In his current role he oversees the regulatory strategy for a number of projects in clinical development through to marketing submissions. He also sits on the impurities advisory group within AstraZeneca and the AstraZeneca nitrosamines risk management team. Externally to AstraZeneca he is a visiting lecturer at Sheffield University and represents AstraZeneca on the European Federation of Pharmaceutical Industries and Associations (EFPIA) and IQ consortium nitrosamine teams and the EPOC regulatory sub team.